These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8674233)

  • 1. DNA methylation: a potential pathway to abnormal autoreactive lupus B cells.
    Huck S; Zouali M
    Clin Immunol Immunopathol; 1996 Jul; 80(1):1-8. PubMed ID: 8674233
    [No Abstract]   [Full Text] [Related]  

  • 2. The etiopathogenesis of systemic lupus erythematosus.
    Quimby FW; Schwartz RS
    Pathobiol Annu; 1978; 8():35-59. PubMed ID: 214738
    [No Abstract]   [Full Text] [Related]  

  • 3. Emerging and critical issues in the pathogenesis of lupus.
    Gatto M; Zen M; Ghirardello A; Bettio S; Bassi N; Iaccarino L; Punzi L; Doria A
    Autoimmun Rev; 2013 Feb; 12(4):523-36. PubMed ID: 23000207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Disseminated lupus erythematosus: etiopathogenic factors].
    Dandavino R; Bach JF
    Ann Med Interne (Paris); 1977 Jan; 128(1):39-41. PubMed ID: 301002
    [No Abstract]   [Full Text] [Related]  

  • 5. DNA methylation in T cells from idiopathic lupus and drug-induced lupus patients.
    Zhou Y; Lu Q
    Autoimmun Rev; 2008 May; 7(5):376-83. PubMed ID: 18486925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2007 Changsha International Symposium on Lupus.
    Lu QJ; Li YP
    Chin Med J (Engl); 2007 Aug; 120(16):1471-2. PubMed ID: 17825185
    [No Abstract]   [Full Text] [Related]  

  • 7. Antibodies and other biomarkers - pathological consequences (2).
    Ehrenstein MR; Alves JD
    Lupus; 2008 Mar; 17(3):256-8. PubMed ID: 18372372
    [No Abstract]   [Full Text] [Related]  

  • 8. The potential role of immunoregulatory disturbance in the pathogenesis of systemic lupus erythematosus.
    Bell DA
    J Rheumatol; 1981; 8(2):340-4. PubMed ID: 6971937
    [No Abstract]   [Full Text] [Related]  

  • 9. Do cytokines play a role in systemic lupus erythematosus?
    Singh AK
    J R Coll Physicians Lond; 1992 Oct; 26(4):374-6. PubMed ID: 1432876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of T and B lymphocytes in the pathogenesis of systemic lupus erythematosus].
    Gliński W
    Przegl Dermatol; 1976; 63(4):505-12. PubMed ID: 788057
    [No Abstract]   [Full Text] [Related]  

  • 11. Antinuclear antibodies in systemic lupus erythematosus.
    Hamashima Y
    Acta Pathol Jpn; 1965 Nov; 15(4):430-6. PubMed ID: 4958072
    [No Abstract]   [Full Text] [Related]  

  • 12. [Advances in research on relationship between DNA hypomethylation and systemic lupus erythematosus].
    Li ZZ; Zheng M
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2006 Jul; 35(4):458-62. PubMed ID: 16924715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant expression of Fas ligand on anti-DNA autoantibody secreting B lymphocytes in patients with systemic lupus erythematosus: "immune privilege"-like state of the autoreactive B cells.
    Nagafuchi H; Wakisaka S; Takeba Y; Takeno M; Sakane T; Suzuki N
    Clin Exp Rheumatol; 2002; 20(5):625-31. PubMed ID: 12412192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired DNA methylation and its mechanisms in CD4(+)T cells of systemic lupus erythematosus.
    Zhang Y; Zhao M; Sawalha AH; Richardson B; Lu Q
    J Autoimmun; 2013 Mar; 41():92-9. PubMed ID: 23340289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of antilymphocytic antibodies in the pathogenesis of systemic lupus erythematosus].
    Gliński W
    Przegl Dermatol; 1976; 63(5):699-705. PubMed ID: 1087422
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of T cell DNA methylation in lupus syndromes.
    Yung RL; Richardson BC
    Lupus; 1994 Dec; 3(6):487-91. PubMed ID: 7535621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Idiotypes in systemic lupus erythematosus. Clues for understanding etiology and pathogenicity.
    Shefner R; Manheimer-Lory A; Davidson A; Paul E; Aranow C; Katz J; Diamond B
    Chem Immunol; 1990; 48():82-108. PubMed ID: 2294929
    [No Abstract]   [Full Text] [Related]  

  • 18. Annexin A1 as a target for managing murine pristane-induced systemic lupus erythematosus.
    Mihaylova N; Bradyanova S; Chipinski P; Herbáth M; Chausheva S; Kyurkchiev D; Prechl J; Tchorbanov AI
    Autoimmunity; 2017 Jun; 50(4):257-268. PubMed ID: 28300427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral B cell abnormalities and disease activity in systemic lupus erythematosus.
    Hostmann A; Jacobi AM; Mei H; Hiepe F; Dörner T
    Lupus; 2008 Dec; 17(12):1064-9. PubMed ID: 19029273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defective B cell tolerance checkpoints in systemic lupus erythematosus.
    Yurasov S; Wardemann H; Hammersen J; Tsuiji M; Meffre E; Pascual V; Nussenzweig MC
    J Exp Med; 2005 Mar; 201(5):703-11. PubMed ID: 15738055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.